ARPC2 and glioblastoma: The PFI results indicated that an elevated ARPC2 expression predicted worse PFI in patients with ACC, HNSC, GBM, KIRC, KIRP, LGG, PAAD, PRAD, UCEC, and UVM (Supplementary Figure S2).